Steph & Co. Lowers Stock Position in Avantor, Inc. (NYSE:AVTR)

Steph & Co. lessened its stake in shares of Avantor, Inc. (NYSE:AVTR) by 3.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,057 shares of the company’s stock after selling 637 shares during the quarter. Steph & Co.’s holdings in Avantor were worth $338,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in AVTR. UMB Bank n.a. purchased a new stake in shares of Avantor during the 3rd quarter worth $49,000. Nisa Investment Advisors LLC lifted its position in shares of Avantor by 69.6% during the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after buying an additional 835 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Avantor by 89.9% in the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after buying an additional 1,285 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt grew its position in shares of Avantor by 278.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock worth $130,000 after buying an additional 3,700 shares during the last quarter. Finally, Quarry LP raised its stake in shares of Avantor by 4,489.1% during the 2nd quarter. Quarry LP now owns 6,333 shares of the company’s stock worth $134,000 after acquiring an additional 6,195 shares in the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Stock Up 0.5 %

AVTR stock opened at $21.82 on Thursday. The company has a market capitalization of $14.85 billion, a P/E ratio of 47.43, a price-to-earnings-growth ratio of 3.42 and a beta of 1.28. Avantor, Inc. has a 12 month low of $19.59 and a 12 month high of $28.00. The firm’s fifty day simple moving average is $21.49 and its 200-day simple moving average is $23.36. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on AVTR shares. Wells Fargo & Company cut their price target on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. UBS Group dropped their target price on Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a research note on Tuesday, October 8th. Robert W. Baird lowered their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a report on Monday, October 28th. Royal Bank of Canada restated an “outperform” rating and set a $34.00 price target on shares of Avantor in a research note on Thursday, September 26th. Finally, Barclays decreased their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat, Avantor has a consensus rating of “Moderate Buy” and an average target price of $27.69.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.